The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis

Infection

Volumn 40, Issue 1, 2012, Pages 77-80

  Busca, A ^a   Limerutti, G ^a   Locatelli, F ^a   Barbui, A ^a   De Rosa, F G ^b   Falda, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Invasive fungal infection; Stem cell transplantation; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BUSULFAN; CASPOFUNGIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFERASIROX; FLUCONAZOLE; LEVOFLOXACIN; METHOTREXATE; PIPERACILLIN PLUS TAZOBACTAM; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LIVER INJURY; LUNG MYCOSIS; MALE; PNEUMOTHORAX; RHIZOPUS; RHIZOPUS MICROSPORUS; STEM CELL TRANSPLANTATION; ZYGOMYCOSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BENZOIC ACIDS; ECHINOCANDINS; FATAL OUTCOME; FEMALE; HUMANS; IRON CHELATING AGENTS; LUNG; LUNG DISEASES, FUNGAL; MIDDLE AGED; MUCORMYCOSIS; RHIZOPUS; STEM CELL TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 84857787704     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0156-y     Document Type: Article

References (21)

1. L Pagano M Caira A Candoni, et al. 2006 The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study Haematologica 91 1068 1075 16885047 (Pubitemid 44208634)
2. D Neofytos D Horn E Anaissie, et al. 2009 Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) alliance registry Clin Infect Dis 48 265 273 19115967 10.1086/595846 1:CAS:528:DC%2BD1MXivVSlsLY%3D
3. Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am J Roentgenol 2003; 180:1251-44.
4. RE Benamore GL Weisbrod M Hwang, et al. 2007 Reversed halo sign in lymphomatoid granulomatosis Br J Radiol 80 162 166 10.1259/bjr/46361210
5. R Agarwal AN Aggarwal D Gupta 2007 Another cause of halo sign: Wegener's granulomatosis Br J Radiol 80 849 850 17959924 10.1259/bjr/61353689 1:STN:280:DC%2BD2snjsFCntg%3D%3D (Pubitemid 350205525)
6. EL Gasparetto DL Escuissato T Davaus, et al. 2005 Reversed halo sign in pulmonary paracoccidioidomycosis AJR Am J Roentgenol 184 1932 1934 15908556 (Pubitemid 40770174)
7. E Marchiori RD Grando CE Simões dos Santos, et al. 2010 Pulmonary tuberculosis associated with the reversed halo sign on high-resolution CT Br J Radiol 83 58 60 10.1259/bjr/22699201
8. H Wahba MT Truong X Lei, et al. 2008 Reversed halo sign in invasive pulmonary fungal infections Clin Infect Dis 46 1733 1737 18419427 10.1086/587991 (Pubitemid 351706772)
9. Marchiori E, Godoy MC, Zanetti G, Hochhegger B, Rodrigues RS. The reversed halo sign. Another CT finding useful for distinguish invasive pulmonary aspergillosis and pulmonary lymphoma Eur J Radiol. 2011. doi: 10.1016/j.ejrad.2011.03.086.
10. JH Chung DJ Godwin JW Chien SJ Pipavath 2010 Pulmonary mucormycosis Radiology 256 667 670 20656848 10.1148/radiol.10081907
11. KA Marr RA Carter F Crippa A Wald L Corey 2002 Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 34 909 917 11880955 10.1086/339202 (Pubitemid 34229758)
12. B Brad Spellberg TJ Walsh DP Kontoyiannis J Edwards AS Ibrahim 2009 Recent advances in the management of mucormycosis: from bench to bedside Clin Infect Dis 48 1743 1751 19435437 10.1086/599105
13. MM Roden TE Zaoutis WL Buchanan TA Knudsen TA Sarkisova RL Schaufele M Sein T Sein CC Chiou JH Chu DP Kontoyiannis TJ Walsh 2005 Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 634 653 16080086 10.1086/432579 (Pubitemid 41170352)
14. Skiada A, Pagano L, Groll A, et al. for the European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011. doi: 10.1111/j.1469-0691.2010.03456.x.
15. G Chamilos RE Lewis DP Kontoyiannis 2008 Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis Clin Infect Dis 47 503 509 18611163 10.1086/590004
16. Ballester F, Pastor FJ, Guarro J. In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus. J Antimicrob Chemother. 2008; 61:755-7. (Pubitemid 351321162)
17. AS Ibrahim T Gebremariam Y Fu JE Edwards Jr B Spellberg 2008 Combination echinocandin-polyene treatment of murine mucormycosis Antimicrob Agents Chemother 52 1556 1558 18212099 10.1128/AAC.01458-07 1:CAS:528: DC%2BD1cXksFajuro%3D (Pubitemid 351522035)
18. Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47:364-71.
19. C Reed A Ibrahim JE Edwards Jr I Walot B Spellberg 2006 Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis Antimicrob Agents Chemother 50 3968 3969 17000743 10.1128/AAC.01065-06 (Pubitemid 44684931)
20. AS Ibrahim T Gebermariam Y Fu, et al. 2007 The iron chelator deferasirox protects mice from mucormycosis through iron starvation J Clin Invest 117 2649 2657 17786247 10.1172/JCI32338 1:CAS:528:DC%2BD2sXhtVCms7nO (Pubitemid 47494365)
21. A Busca F Marmont F Locatelli, et al. 2010 Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy Mycoses 53 275 278 19302458 10.1111/j.1439-0507.2009.01708.x